Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Boston Scientific (BSX) through the VizualStocks API.
Adjusted operating income from Boston Scientific's devices for coronary and peripheral interventions, heart rhythm management, electrophysiology, structural heart treatment and interventional oncology.
cardiovascularSegmentAdjustedOperatingIncomeNet sales of Boston Scientific's devices for coronary and peripheral interventions, heart rhythm management, electrophysiology, structural heart treatment and interventional oncology.
cardiovascularSegmentNetSalesYear-over-year net-sales growth from Boston Scientific's Cardiovascular businesses after removing the effects of foreign-currency movements and recent acquisitions and divestitures, exposing growth in the comparable device portfolio.
cardiovascularSegmentOrganicNetSalesGrowthAdjusted operating income from Boston Scientific's Endoscopy, Urology and Neuromodulation businesses, which sell minimally invasive devices for digestive, pulmonary, urological, neurological and chronic-pain conditions.
medsurgSegmentAdjustedOperatingIncomeNet sales from Boston Scientific's Endoscopy, Urology and Neuromodulation businesses, which sell minimally invasive devices for digestive, pulmonary, urological, neurological and chronic-pain conditions.
medsurgSegmentNetSalesYear-over-year net-sales growth from Boston Scientific's Endoscopy, Urology and Neuromodulation businesses after removing foreign-currency movements and recent acquisitions and divestitures.
medsurgSegmentOrganicNetSalesGrowthRevenue Boston Scientific reports for reportable business segments not separately disclosed in its reportable segment breakdown during the period, measured in U.S. dollars.
otherRevenueUnallocated Boston Scientific corporate expenses, including hedging activities and foreign-currency effects on reportable-segment operating income, during the period.
unallocatedCorporateExpenses